New molecular insights into osteosarcoma targeted therapy

被引:274
|
作者
Yang, Jilong [1 ]
Zhang, Wei [2 ]
机构
[1] Tianjin Med Univ Canc Hosp & Inst, Dept Bone & Soft Tissue Tumors, Tianjin 300060, Peoples R China
[2] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
关键词
genetic aberration; microRNA; molecular target; osteosarcoma; pathogenesis; TUMOR-GROWTH; GENE-EXPRESSION; CELL-LINES; IN-VITRO; PATHWAY; METASTASIS; OVEREXPRESSION; APOPTOSIS; PROTEIN; CANCER;
D O I
10.1097/CCO.0b013e3283622c1b
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of reviewRecent translational studies in osteosarcoma are discussed with the purpose to shed light on the new molecular therapeutic targets.Recent findingsThe genetic aberrations of vascular endothelial growth factor (VEGF), mammalian target of rapamycin, Wnt signaling pathway, the inactivation of p53, Rb, WWOX genes, and amplification of APEX1, c-myc, RECQL4, RPL8, MDM2, VEGFA might be involved in the pathogenesis of osteosarcoma. The promising therapeutic targets for osteosarcoma patients include: integrin, ezrin, statin, NOTCH/HES1, matrix metalloproteinases (MMPs), m-calpain, and Src, which are involved in tumor cell invasion and metastasis; aldolase A, fructose-bisphosphate, sulfotransferase family 3A, member 1, BCL2-associated athanogene 3, heat shock protein 70 (HSP70), B-cell lymphoma 2-interacting mediator (BIM), polo-like kinase 1, hypoxia inducible factor 1, alpha subunit, minibrain-related kinase, Bcl-xl, caspase-3, midkine, high mobility group box 1 protein (HMGB1), and Beclin1, which are involved in tumor proliferation and apoptosis; met proto-oncogene (hepatocyte growth factor receptor), v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, insulin-like growth factor (IGF)-1R, fms-related tyrosine kinase 4, platelet-derived growth factor receptor, beta polypeptide, IGF-I/II, and c-kit, which are involved in tumor growth; endosialin, VEGF, thrombin, and MMPs, which are involved in tumor angiogenesis; transforming growth factor-/, parathyroid hormone-like hormone, interleukin-6, interleukin-11, receptor activator of nuclear factor-B ligand, nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1, and cathepsin, which are involved in osteoclast function; Myc, HSP90, p-Met, p-Akt, p-STAT3, and cyclin D1, which are transcriptional factors; p-GP, hydroxysteroid (17-beta) dehydrogenase 10, HMGB1, BIM, inorganic phosphate, Bcl-2, PARP, mdm2, p21, Bax, and mitogen-activated protein kinase 1, which are involved in drug sensitivity. Furthermore, microRNAs such as miR-215 are also therapeutic targets.SummaryThese translational studies in osteosarcoma have identified new molecular targets for osteosarcoma.
引用
收藏
页码:398 / 406
页数:9
相关论文
共 50 条
  • [31] New Developments in Molecular Targeted Therapy of Ovarian Cancer
    Guan, Lu-Yao
    Lu, Yuan
    DISCOVERY MEDICINE, 2018, 26 (144) : 219 - 229
  • [32] New insights for the diagnosis and management of right ventricular failure, from molecular imaging to targeted right ventricular therapy
    Haddad, Francois
    Ashley, Euan
    Michelakis, Evangelos D.
    CURRENT OPINION IN CARDIOLOGY, 2010, 25 (02) : 131 - 140
  • [33] New insights into neuroendocrine tumors: molecular biology, imaging and targeted therapies
    Rohmer, Vincent
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2010, 194 (01): : 97 - 104
  • [34] Molecular targeted therapy
    Stenner-Liewen, F.
    Zippelius, A.
    Pestalozzi, B. C.
    Knuth, A.
    CHIRURG, 2006, 77 (12): : 1118 - +
  • [35] Molecular targeted therapy
    Doerr, W.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 58 - 59
  • [36] From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer
    Levine, MN
    Lee, AY
    Kakkar, AK
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (07) : 1456 - 1463
  • [37] New Insights into Molecular Oncogenesis and Therapy of Uveal Melanoma
    Violanti, Sara Silvia
    Bononi, Ilaria
    Gallenga, Carla Enrica
    Martini, Fernanda
    Tognon, Mauro
    Perri, Paolo
    CANCERS, 2019, 11 (05)
  • [38] Molecular genetics of human leukemias: New insights into therapy
    Gilliland, DG
    SEMINARS IN HEMATOLOGY, 2002, 39 (04) : 6 - 11
  • [39] Insights into the roles of miRNAs; miR-193 as one of small molecular silencer in osteosarcoma therapy
    Izadpanah, Sama
    Shaban, Parastoo
    Aghebati-Maleki, Ali
    Baghbani, Elham
    Baghbanzadeh, Amir
    Fotouhi, Ali
    Bakhshinejad, Babak
    Aghebati-Maleki, Leili
    Baradaran, Behzad
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 111 : 873 - 881
  • [40] Exploring targeted therapy of osteosarcoma using proteomics data
    Chaiyawat, Parunya
    Settakorn, Jongkolnee
    Sangsin, Apiruk
    Teeyakasem, Pimpisa
    Klangjorhor, Jeerawan
    Soongkhaw, Aungsumalee
    Pruksakorn, Dumnoensun
    ONCOTARGETS AND THERAPY, 2017, 10 : 565 - 577